Elinzanetant

Overview

Elinzanetant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4802157).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Elinzanetant expires 14 May 2045 and exclusivity 24 Oct 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

N-[6-[(7S,9aS)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)-3-pyridinyl]-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide

Canonical SMILES

CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4C[C@H]5COCCN5C[C@H]4CO

InChIKey

DWRIJNIPBUFCQS-DQEYMECFSA-N